Chimerix Inc
NASDAQ:CMRX
| Market Cap (Intraday) | 728.06M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.38 |
| 50-Day MA | $8.39 |
| 200-Day MA | $6.38 |
Chimerix Inc Stock, NASDAQ:CMRX
2505 Meridian Parkway, Suite 100, Durham, North Carolina 27713
United States of America
Phone: +1.919.806.1074
Number of Employees: 54
Description
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.